Stock Information
MBX Biosciences Inc (MBX)
Ticker Symbol: MBX
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,481.33 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.4179
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -28.72%
Latest News
-
MBX Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Thu, May 7, 2026 12:22 PM
-
MBX Biosciences : Company Overview - May 2026
Thu, May 7, 2026 8:27 AM
-
MBX Biosciences Q1 EPS $(0.51) Beats $(0.61) Estimate
Thu, May 7, 2026 8:13 AM
-
MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights
Thu, May 7, 2026 8:02 AM
-
MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award
Thu, May 7, 2026 7:03 AM
Key Financials
Financial data not available